𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiosynthesis of novel 18F-labelled derivatives of indiplon as potential GABAA receptor imaging tracers for PET

✍ Scribed by Steffen Fischer; Achim Hiller; Matthias Scheunemann; Winnie Deuther-Conrad; Alexander Hoepping; Michael Diekers; Florian Wegner; Peter Brust; Jörg Steinbach


Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
246 KB
Volume
51
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The involvement of gamma amino butyric acid (GABA) receptors in a variety of neurological and psychiatric diseases has promoted the development and use of radiolabelled benzodiazepines (BZ) for brain imaging by PET. However, these radioligands are unable to distinguish between the various subtypes of GABA~A~ receptors. Novel non‐BZ such as the pyrazolo‐pyrimidine indiplon proved to be selective for the α~1~‐subunit of the GABA~A~ receptor. Here, we describe the syntheses of four novel ^18^F‐labelled indiplon derivatives. Radiosyntheses were performed via n.c.a. ^18^F‐nucleophilic substitution starting from the tosyl, bromo, and 4‐nitrobenzoyl precursors to obtain fluorine substituted N‐alkylamide side chain derivatives of indiplon, followed by multistep purification using semi‐preparative high‐performance liquid chromatography and solid phase extraction. Tosyl and bromo precursors were converted into ^18^F‐labelled indiplon derivatives with good and reproducible radiochemical yield (RCY) (35–70%, decay corrected), high radiochemical purity (≥98.5%), and high specific activity ( > 150 GBq/µmol). By contrast, a low RCY (5–10%) and specific activity (10–15 GBq/µmol) were achieved for the 4‐nitrobenzoyl precursor. Copyright © 2008 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Radiosynthesis of O-[11C]methyl-L-tyrosi
✍ Ren Iwata; Shozo Furumoto; Claudio Pascali; Anna Bogni; Kiichi Ishiwata 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 140 KB

## Abstract Two positron‐emitting analogues of tyrosine, __O__‐[^11^C]methyl‐L‐tyrosine and __O__‐[^18^F]fluoromethyl‐L‐tyrosine were prepared as new tumor imaging agents. The alkylating agent, [^11^C]methyl triflate or [^18^F]fluoromethyl triflate, was simply bubbled through a dimethylsulfoxide so

A 18F-Labeled Fluorobutyl-Substituted Sp
✍ Dr. Aurélie Maisonial; Dr. Eva Große Maestrup; Dr. Steffen Fischer; Dr. Achim Hi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

## Abstract In this study, we synthesized and evaluated a new spirocyclic piperidine derivative 3, containing a 4‐fluorobutyl side chain, as a PET radioligand for neuroimaging of σ~1~ receptors. In vitro, compound 3 displayed high affinity for σ~1~ receptors (__K__~i~=1.2 nM) as well as high select

Radiosynthesis of 123I-labelled benzimid
✍ Sue Champion; Jonathan Gross; Albert J Robichaud; Sally Pimlott 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB

The histamine H3 receptor is implicated in many neurological and psychological disorders and is therefore of interest as a target for pharmacological intervention. The drug development process can be facilitated by using a radiotracer for this receptor in conjunction with single‐photon emission comp

In vitro binding profile and radiosynthe
✍ Barbara Wenzel; Achim Hiller; Steffen Fischer; Dietlind Sorger; Winnie Deuther-C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB

## Abstract Radiolabeled vesamicol analogs are promising candidates as ligands for the vesicular acetylcholine transporter (VAChT) to enable __in vivo__ imaging of early cholinergic degenerations in brain. The 4‐fluorobenzoyl‐substituted azaspirovesamicol derivative FBASV is one out of six novel ve

Fluorine-18 labeling of 6,7-disubstitute
✍ Yann Seimbille; Michael E. Phelps; Johannes Czernin; Daniel H. S. Silverman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 157 KB

Inhibitors of tyrosine kinase enzymatic activity represent a promising new class of antineoplastic agents. Although clinical studies performed over the last decade give more insight on the potential therapeutic applications of such drugs, identification of the individual patients who might benefit f